AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CAMT

Camtek Ltd. Ordinary Shares (CAMT) fair value

Technology · Semiconductor Equipment & Materials · NASDAQ · United States
$121.16+1.41%
Market cap $5.7BNext earnings 2026-11-04Updated Oct 24, 2026
Add earnings to calendarGoogle
Our verdict
Trades 28% above our fair value
Price
$121.16
Model fair valueConfidence: medium
$94.58
Only one of our models could value this stock with confidence, so use it as a guide.
Not used by alerts or posts.
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionCamtek Ltd. Ordinary Shares (CAMT)
Fair value (2 models)
Not available
ACCE price target
$141
Rating
Not rated
Horizon
12 months
ACCE price target published on 10 Oct 2026, 00:00 CEST.
Price used: $121 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
34
out of 100
Analysts
58% buy
12 covering
P/E
186.4x
forward 28.2x
1-year return
+2.6%
Dividend yield
0.00%

Camtek Ltd. Ordinary Shares in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Camtek makes process control and inspection systems for advanced semiconductor packaging, including the Eagle and Hawk platforms used to inspect wafers and substrates for high-bandwidth memory and advanced packaging lines. Its edge is a narrow niche where chipmakers need metrology tools that can catch defects in 2.5D and 3D packaging, a segment that is growing faster than the broader equipment market. Revenue growth has been muted at 2.5% and the trailing P/E of 199 reflects depressed earnings, while the forward P/E of 29.9 implies the market expects a sharp earnings recovery. A 51% gross margin and 22.4% operating margin are healthy for hardware, but ROE of 7.6% and a 0 index membership suggest the market has not yet rewarded the business. The question for a deeper look is whether packaging demand from AI-driven memory and logic programs converts into the earnings step-up that the forward multiple already assumes.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Earnings declining despite valuation
    Earnings fell 10.0% YoY while the stock trades at a trailing P/E of 227.1 and EV/EBITDA of 153.3, leaving little margin for error on the forward P/E of 29.9.
  • moderate
    Revenue growth slowing sharply
    Revenue grew only 2.5% YoY against a 5-year CAGR of 26.1%, a sharp deceleration that the 9.5% QoQ gain does not fully offset.
  • moderate
    Score down 7 points in 90 days
    The ACCE score fell from 45 to 38 over 90 days, with the Value component at 24 and Growth at 19 weighing on the total.

AI research notes

AI-assisted·How I use AIWritten Oct 13, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Analysts remain constructive, with 58% rating the stock Buy or Strong Buy and a mean target above the current price.
  • Five-year revenue growth averaged 26.1% a year, showing the business has expanded quickly over a long stretch.
  • Trailing earnings beat expectations last quarter, with earnings per share of 0.69 against 0.67 expected.
Why it could disappoint
  • Revenue grew only 2.5% over the last year, a sharp slowdown from the long-run pace.
  • At $147.63 the stock trades far above the consensus fair value of $73.38, a gap of 50.3%.
  • The forward multiple of 29.9x sits above the sector median of 29.3x while return on invested capital is only 3.7%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CAMT's valuation models land
Price
$121.16
Model fair valueConfidence: medium
$94.58
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Mixed58% buy · 12 covering analysts
● Strong buy 5● Buy 2● Hold 5● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
0 buys · 10 sells
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-6.4%
1 month
-17.6%
3 months
-18.0%
6 months
-40.3%
YTD
+13.9%
1 year
+2.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTFair value$72.04$73.38$143
10 Oct 2026, 00:00 CESTACCE price target$141first publication$151
10 Oct 2026, 00:00 CESTFair value$73.38$59.98$151
6 Oct 2026, 00:00 CESTFair value$59.98$61.68$165
4 Oct 2026, 00:00 CESTFair value$61.68$60.65$165
20 Sept 2026, 00:00 CESTFair value$60.65$59.61$149
18 Sept 2026, 00:00 CESTFair value$59.61$57.95$139
16 Sept 2026, 00:00 CESTFair value$57.95$75.67$134
13 Sept 2026, 00:00 CESTFair value$75.67$60.21$148
11 Sept 2026, 00:00 CESTFair value$60.21$61.17$149

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CAMT page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth19Value24Quality62Momentum32Total34
Valuation
Trailing P/E
186.4x
Forward P/E
28.2x
PEG
no data
P/B
9.11x
EV / Revenue
12.4x
Book value/sh
$13.46
Enterprise value
$6.3B
Profitability
ROE
7.6%
FCF yield
2.25%
ROIC
3.7%
Health and risk
Debt / equity
0.84
Dividend yield
0.00%
Beta
1.59

Price

+1.7% · 1Y

Ask anything about CAMT

Answered from Camtek Ltd. Ordinary Shares fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 0% of peers
low 25.0x186.4xhigh 186.4x
ROEbetter than 33% of peers
low -15%8%high 16%
Div yieldbetter than 33% of peers
low 0.0%0.0%high 1.9%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CAMT Camtek Ltd. Ordinary Shares$121.16--186.4x7.6%6234
3436.T Sumco Corporation¥2347.50----4.1%2749
SOI.PA Soitec SA€111.65----15.2%3135
FORM FormFactor Inc. FormFactor Inc. Common Stock$98.51--67.9x11.0%7459
6323.T Rorze Corporation¥3657.00--26.8x16.4%8374
7729.T Tokyo Seimitsu Co., Ltd.¥15520.00--25.0x14.4%7969
KLIC Kulicke and Soffa Industries Inc. Common Stock$73.71$30147% above33.8x13.2%7958

Sector report card

Where CAMT ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Oct 7, 2026
    CAMTEK TO HOST INVESTOR & ANALYST BREAKFAST AT SEMICON WEST ON OCTOBER 14, 2026
  • PR Newswire•Jun 2, 2026
    CAMTEK RECEIVES OVER $105 MILLION MULTI-SYSTEM ORDERS FROM A TIER-1 OSAT AND A LEADING HBM MANUFACTURER
26 filings of 40
October 2026
Oct 14
6-KForeign current reportPeriod 2026-10-14
View on SEC →
Oct 14
6-KForeign current reportPeriod 2026-10-14
View on SEC →
August 2026
Aug 18
Form 4Insider transactionPeriod 2026-08-17
View on SEC →
23 more filings + AI summaries on Investor+.INVESTOR